Neurology: Volume 85, Number 11, September 15, 2015 – Exam #1
About this course
- Released: 9/15/2015
- Expires: 9/15/2018
PERAMPANEL FOR TONIC-CLONIC SEIZURES IN IDIOPATHIC GENERALIZED EPILEPSY: A RANDOMIZED TRIAL
Upon completion of the article by French et al, the participant should be able to:
- Recognize that few antiepileptic drugs are licensed to treat primary generalized tonic-clonic (PGTC) seizures
- State the mechanism of action of perampanel
- Discuss the findings from this study assessing the efficacy of perampanel in patients with drug-resistant PGTC seizures in idiopathic generalized epilepsy (IGE)
- List the most frequent treatment-emergent adverse events (TEAE) seen with perampanel in this study
The article by French al covers the following core competency:
- Medical Knowledge
Refer to listing above the references in each article.
THIS PAGE IS REQUIRED READING BEFORE BEGINNING ALL ACCME-ACCREDITED COURSES
The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed. Physicians should only claim credit commensurate with the extent of their participation in the activity. The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
MISSION STATEMENT/PROGRAM OBJECTIVES
After evaluating a specific article published in Neurology, participants in the CME activity should be able to demonstrate an increase in, or affirmation of, their knowledge of clinical medicine. Participants should be able to evaluate the appropriateness of the clinical information as it applies to the provision of patient care.
This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.
The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed.
The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.
Steven Lewis, MD receives a stipend in his editorial capacity for Neurology and as an Associate Editor for Continuum: Lifelong Learning in Neurology; has received royalties for the books Field Guide to the Neurologic Examination and Neurology for the Non-Neurologist; and anticipates receiving royalties for the book Neurologic Disorders due to Systemic Disease. James WM Owens Jr. MD, PhD receives royalties from UpToDate, Waltham, MA; grant support from NIH (PI, K08NS054882); and a stipend in his editorial capacity for Neurology.
This CME program receives no commercial support.